A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
Inogen, Inc. is a medical technology business that primarily focuses on respiratory health. We develop, manufacture, and market innovative respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox® product for airway clearance treatment. In addition, we have started distributing the Inogen Voxi® 5 stationary oxygen concentrator as well as the Aurora® continuous positive airway pressure, or CPAP, masks in the United States. Our proprietary Inogen One® and Inogen Rove® POC systems concentrate the air around the patient to offer a source of supplemental oxygen 24 hours a day, seven days a week with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 349M | 349M | 336M | 316M | 377M | 358M |
| Net Income | -23M | -23M | -36M | -102M | -84M | -6.3M |
| EPS | $-0.86 | $-0.86 | $-1.52 | $-4.42 | $-3.67 | $-0.28 |
| Free Cash Flow | -14M | -14M | 2.6M | -8.5M | -41M | 18M |
| ROIC | -27.0% | -11.8% | -20.6% | -50.0% | -28.2% | 4.1% |
| Gross Margin | 44.2% | 44.2% | 46.1% | 40.1% | 40.7% | 49.3% |
| Debt/Equity | 0.00 | 0.55 | 0.70 | 0.59 | 0.36 | 0.32 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | -30M | -30M | -43M | -109M | -85M | 9.2M |
| Operating Margin | -8.7% | -8.7% | -12.7% | -34.7% | -22.6% | 2.6% |
| ROE | -11.8% | -12.4% | -20.6% | -50.0% | -28.2% | -1.7% |
| Shares Outstanding | 26M | 26M | 24M | 23M | 23M | 23M |
Inogen Inc passes 1 of 9 quality checks, indicating weak fundamentals.
The company's 5-year average gross margin is 44.1%. At current prices, the estimated annualized return to fair value is -19.4%.
Inogen Inc (INGN) has a 5-year average return on invested capital (ROIC) of -21.3%. This is below average and may indicate limited pricing power.
Inogen Inc (INGN) has a market capitalization of $168M. It is classified as a small-cap stock.
Inogen Inc (INGN) does not currently pay a regular dividend.
Inogen Inc (INGN) operates in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry, within the Healthcare sector.
Inogen Inc (INGN) reported annual revenue of $349 million in its most recent fiscal year, based on SEC EDGAR filings.
Inogen Inc (INGN) has a net profit margin of -6.5%. The company is currently unprofitable.
Inogen Inc (INGN) generated $-14 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
Inogen Inc (INGN) has a debt-to-equity ratio of 0.55. This indicates moderate leverage.
Inogen Inc (INGN) reported earnings per share (EPS) of $-0.86 in its most recent fiscal year.
Inogen Inc (INGN) has a return on equity (ROE) of -12.4%. A negative ROE may indicate losses or negative equity.
Inogen Inc (INGN) has a 5-year average gross margin of 44.1%. This indicates decent pricing power.
The Ledger Terminal provides 14 years of financial data for Inogen Inc (INGN), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Inogen Inc (INGN) has a book value per share of $7.27, based on its most recent annual SEC filing.